The department at Uría Menéndez is a strong choice for regulatory matters, commercial transactions and IP work in the life science sphere. Core areas of expertise include pricing and market access strategies, regulatory compliance and the commercialisation of new drugs. Leadership is shared between Beatriz Cocina, Montiano Monteagudo, Ingrid Pi and Francisco Javier García. Cocina’s broad practice takes in contractual, commercial, administrative and regulatory mandates; Monteagudo handles IP, competition and corporate law matters; Pi focuses on IP and competition litigation; and García, for his part, specialises in IP litigation and data privacy matters.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- ‘I believe what makes it different is its availability, attention to detail, both to the specific project and to the overall vision of our organisation, which fosters understanding and the achievement of the results we request with great accuracy.’
- ‘Both Francisco Javier Pérez and María Ángeles Díaz always offer us an open approach and a deep understanding of the specific and particular needs of our organisation, which allows us to provide tailored advice that, in turn, offers ideal solutions to our internal clients.’
- ‘Extensive knowledge of the sector, a wealth of historical context on how it has evolved. I believe one of Uría's truly distinguishing aspects is the high level of service you receive directly from its partner. It's exceptionally high quality, and you don't waste time with intermediaries who might be less efficient or couldn't offer the best advice.’
- ‘In my experience, what makes this team stand out is their deep understanding of the sector and their ability to combine regulatory, commercial, and market expertise. For me, Beatriz Cocina is the leading expert in Spain (and beyond) on regulatory and commercial matters, while Francisco Javier García is the top expert in digital health and unfair competition within the sector. They not only master the regulations but also understand the market and know how to identify what clients truly need.'
- ‘The team has a client-oriented vision combined with one of the deepest knowledge of the sector and the regulatory environment. They have a great approach when facing legal challenges, and have always presented a very out-of-the-box approach with great outcomes.’
- ‘Francisco Javier García is outstanding, proactive and fun to work with. No matter how serious the problem, it is a pleasure working together, he's listening, creative and very hands-on, leading a top-notch team that is ready to tackle no matter how serious an issue one presents.’
Key clients
- Farmaindustria (Spanish Pharmaceutical Industry Association)
- GlaxoSmithKline
- Johnson & Johnson
- Lilly
- Novo Nordisk
- Laboratorios Rovi
- Gilead
- Astrazeneca
- Boehringer
- Universal Diagnostics, S.A. (UDx)
- Reckitt Benckiser Healthcare
- Zimmer Biomet
Work highlights
Advising several multinational pharmaceutical companies in connection with the implementation of a new pricing system that differentiates between public and private sales channels.
Advised Glovo on its initiative to integrate pharmacy services into its mobile application.
Advised Laboratorios Rovi on a new manufacturing partnership with a global pharmaceutical company for the supply of bulk drug substances and products in vials and pre-filled syringes.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Beatriz Cocina; Montiano Monteagudo; Ingrid Pi; Francisco Javier García
Other key lawyers
María Ángeles Díaz